Table 2.

Demographic, laboratory and clinical data of all RA patients (n = 64) at study baseline (two years ago).

	Mean ± SD	Range
Age (years)	41.58 ± 11.44	(18–55)
Sex	(45♀, 19♂)	–
DD (years)	5.58 ± 3.7	(3.0–15)
ESR (1st h)	43.27 ± 14.25	(30–95)
CRP (mg%)	25.62 ± 27.4	(4.0–45)
DAS-28	4.18 ± 1.73	(1.8–6.3)
VAS/100 mm	51.25 ± 20.09	(30–100)
SEN score	17.31 ± 9.06	(10–55)
RF titer (U/mL)	106.02 ± 143.12	(12–305)
*Anti-MCV titer (U/mL)	114.45 ± 214.57	(11–329)

Abbreviations: DD, disease duration; VAS, visual analogue scale.

^*Anti-MCV testing was performed for all RA patients only at the study endpoint.